In the PFS study, cox regression of 33 tumors revealed that CYFIP2 expression was substantially linked with PFS in 6 malignancies, with protective factors in BRCA, HNSC, KIRC, LGG, and PAAD and risk factors in UCEC (Figure 11B). The gene discussed is CYFIP2; the disease is pancreatic adenocarcinoma.